WASHINGTON , April 29, 2013 /PRNewswire-USNewswire/ -- Most children with isolated skull fractures may not need to stay in the hospital, which finding has the potential to save the health care system millions of dollars a year ("Isolated Skull Fractures: Trends in Management in U.S. Pediatric Emergency Departments"). In addition, a new device more accurately estimates children's we...
PLYMOUTH, Minn.--(BUSINESS WIRE)--Apr 29, 2013--Monteris Medical announced that their First-In-Humans clinical trial with the NeuroBlate ® System for neurosurgical ablation has been published in the Journal of Neurosurgery. This study was a thermal dose-escalation trial to assess the safety and...
athenahealth, Inc., a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, in partnership with MIT's H@cking Medicine, invites the health care, technology and scientific communities to participate in a Hack-a-Thon on May 4 and 5 at athenahealth's headquarters in Watertown, Mass.
In November 2012, IBM announced that it had used the Blue Gene/Q Sequoia supercomputer to achieve an unprecedented simulation of more than 530 billion neurons. The Blue Gene/Q Sequoia accomplished this feat thanks to its blazing fast speed; it clocks in at over 16 quadrillion calculations per second.
Deep brain stimulation (DBS) in a precise region of the brain appears to reduce caloric intake and prompt weight loss in obese animal models, according to a new study led by researchers at the University of Pennsylvania. The study, reported in the Journal of Neuroscience, reinforces the involvement of dopamine deficits in increasing obesity-related behaviors such as binge eating...
An international team of neuroscientists has described in exhaustive detail the underlying neurobiology of an amnesiac who suffered from profound memory loss after damage to key portions of his brain. EP's story is strikingly similar to the more famous case of HM, who also suffered permanent, dramatic memory loss after small portions of his medial temporal lobes were removed by doctors in 1953 to relieve severe epileptic seizures.
Magnetic resonance imaging measurements of atrophy in an important area of the brain are an accurate predictor of multiple sclerosis (MS), according to a new study published online in the journal Radiology. According to the researchers, these atrophy measurements offer an improvement over current methods for evaluating patients at risk for MS.
Man Undergoes Phrenic Nerve Surgery to Relieve Shortness of Breath, Hopes to Celebrate Recovery by Running a MarathonApril 23, 2013 9:47 am | by PR Newswire | News | Comments
SHREWSBURY, N.J., April 23, 2013 /PRNewswire/ -- Kurt Matthewson went out for his typical run one morning, and quite suddenly, felt shortness of breath and was unable to continue. When the problem persisted he went to a specialist, who administered tests revealing the left side of...
With the recent launch of MIT’s Institute for Medical Engineering and Science, MIT News examines research with the potential to reshape medicine and health care through new scientific knowledge, novel treatments and products, better management of medical data, and improvements in health-care delivery.
How do you make an electronic brain prosthesis that could restore a person’s ability to form long-term memories? Recent experiments by Theodore Berger and his colleagues, including Sam Deadwyler at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, and researchers at the University of Kentucky in Lexington, have begun to describe how it might be done.
The FDA’s UDI rule is on its way and will impact virtually everyone in the industry in one way or another. While the rule has its benefits, getting to compliance will not be achieved overnight. This article provides an overview of the direct part marking technologies required to comply with the UDI rule and offers a solution that addresses the shortcomings of several other technologies.
When my mother tells me that her computer is running slow and she needs me to “clean it up” for her, I never imagined the day she might be calling about the same problem with a medical device. While I’d obviously not have the same access to it that I have on a computer, it does reflect a scary situation in medical device technology today.
Healthcare's First Direct Contracting Market Launches Today; Will Offer Mutually Beneficial Approach for Hospitals and SuppliersApril 22, 2013 9:00 am | by PR Newswire | News | Comments
IRVING, Texas, April 22, 2013 /PRNewswire/ -- Today aptitude announced the launch of the healthcare industry's first online direct contracting market, a one-stop destination designed to complement a hospital's existing contracting model or provide an alternative for those looking...
Engineers on the element14 Community are being invited to develop an intelligent solution for people living with cognitive impairments and other long term conditions that could change their lives. Project Nocturne hopes to find a reliable solution that will alert a relative or carer if their loved one is not safely in bed at night or fails to get up in the morning.
An easy-to-use EEG cap could expand the number of ways to interact with your mobile devices. One day, we may be able to check e-mail or call a friend without ever touching a screen or even speaking to a disembodied helper. Samsung is researching how to bring mind control to its mobile devices with the hope of developing ways for people with mobility impairments to connect to the world.
Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International ConventionApril 18, 2013 9:15 am | by PR Newswire | News | Comments
ROCKVILLE, Md., April 18, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that CEO and President, Richard Garr, will take part in a comprehensive Bio Maryland panel, introduced by Lt. Governor, Anthony Brown, on Maryland's leadership in traumatic brain injury...
Results of Pediatric Clinical Trial of External Trigeminal Nerve Stimulation for the Treatment of ADHDApril 18, 2013 3:01 am | by PR Newswire | News | Comments
LOS ANGELES, April 18, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that the results of the first-ever pediatric clinical trial of external Trigeminal Nerve stimulation (eTNS™) for the treatment of attention-deficit...
Cigarette smoking is the leading cause of preventable deaths globally. Unfortunately smoking cessation is difficult, with more than 90% of attempts to quit resulting in relapse. There are a growing number of available methods that can be tried in the effort to reduce smoking, including medications, behavioral therapies, hypnosis, and even acupuncture.
Medical device maker Boston Scientific acquired the fiXate tissue band from Anulex Technologies, launching the suturing system right away. The fiXate device is a semi-automatic suturing system designed to secure spinal cord stimulator leads and pain pump catheters, touting deployment in under 1 minute in bench testing, according to a press release.
The trickiest thing about the brain mapping project might be that we don’t even know what we’re trying to learn. Brain Research through Advancing Innovative Neurotechnologies (BRAIN) project, which President Obama announced in his State of the Union address in February, will be a decade-long effort to understand the nature of thought.
Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US CongressApril 12, 2013 3:16 pm | by Bio-Medicine.Org | News | Comments
LOS ANGELES , April 12, 2013 /PRNewswire-USNewswire/ -- President Obama said in his April 2 nd speech "We have been a nation of dreamers and risk-takers; people who see what nobody else sees sooner than anybody else sees it. We do innovation better than anybody else -- and that makes our economy stronger. When we invest in the best ideas before anybody else does, our business...
NATICK, Mass., April 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received approval by the U.S. Food and Drug Administration and is beginning a limited launch of the Precision Spectra Spinal Cord Stimulator (SCS) System. The Precision Spectra System is the...
A microscopic light-emitting diode device that controls the activity of neurons has given researchers wireless control over animal behavior. The tiny device, tested in mice, causes less damage than other methods used to deliver light into the brain, report researchers in Thursday’s issue of Science, and it does not tether mice to a light source, enabling scientists to study behaviors more naturally than is normally possible.
Medtech titan Medtronic enrolled the initial patients in its SubQStim II pivotal clinical trial, evaluating the use of peripheral nerve stimulation in treatment of chronic back pain. The new study is the latest in a handful of neurostimulation trials launched by the medical device giant as it continues to battle rivals in the market for neurostimulation systems that treat chronic pain.
For the first time, scientists have been able to predict how much pain people are feeling by looking at images of their brains, according to a new study led by the University of Colorado Boulder. The findings, published today in the New England Journal of Medicine, may lead to the development of reliable methods doctors can use to objectively quantify a patient's pain.